Abiopharma

🔍 HECKER MARK E (Executive)

Company: SOUTHERN MISSOURI BANCORP, INC. (SMBC)

Report Date: 2026-07-29

Detailed Transactions and Holdings:

• Acquired 2,000 shares of Common Stock at $37.31 per share (Direct)
  Date: 2026-07-29 | Code: M | equity_swap_involved: 0 | shares_owned_after: 9,895.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 2,000 shares of Common Stock at $34.35 per share (Direct)
  Date: 2026-07-29 | Code: M | equity_swap_involved: 0 | shares_owned_after: 11,895.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 1,830 shares of Common Stock at $78.31 per share (Direct)
  Date: 2026-07-29 | Code: D | equity_swap_involved: 0 | shares_owned_after: 10,065.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-07-29 | Code: H | nature_of_ownership: 401(k) | shares_owned_after: 2,052.66 | Footnotes: F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-07-29 | Code: H | nature_of_ownership: IRA | shares_owned_after: 10,630.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-07-29 | Code: H | nature_of_ownership: Spouse IRA | shares_owned_after: 185.00
• Sold 2,000 shares of Stock Option (Right to Buy) at $34.35 per share (Derivative)
  Date: 2026-07-29 | Code: M | Expires: 2029-01-04 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F3
• Sold 2,000 shares of Stock Option (Right to Buy) at $37.31 per share (Derivative)
  Date: 2026-07-29 | Code: M | Expires: 2028-01-16 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F4
• Holds 1,500 shares of Stock Option (Right to Buy) at $62.96 per share (Derivative)
  Date: 2026-07-29 | Code: H | Expires: 2036-02-24 | shares_owned_after: 1,500.00 | Footnotes: F5
• Holds 1,500 shares of Stock Option (Right to Buy) at $60.42 per share (Derivative)
  Date: 2026-07-29 | Code: H | Expires: 2035-02-18 | shares_owned_after: 1,500.00 | Footnotes: F6
• Holds 2,500 shares of Stock Option (Right to Buy) at $40.82 per share (Derivative)
  Date: 2026-07-29 | Code: H | Expires: 2034-02-08 | shares_owned_after: 2,500.00 | Footnotes: F7
• Holds 2,500 shares of Stock Option (Right to Buy) at $46.94 per share (Derivative)
  Date: 2026-07-29 | Code: H | Expires: 2033-02-21 | shares_owned_after: 2,500.00 | Footnotes: F8
• Holds 1,500 shares of Stock Option (Right to Buy) at $53.82 per share (Derivative)
  Date: 2026-07-29 | Code: H | Expires: 2032-02-03 | shares_owned_after: 1,500.00 | Footnotes: F9
• Holds 3,000 shares of Stock Option (Right to Buy) at $34.91 per share (Derivative)
  Date: 2026-07-29 | Code: H | Expires: 2031-02-10 | shares_owned_after: 3,000.00 | Footnotes: F10
• Holds 2,000 shares of Stock Option (Right to Buy) at $37.4 per share (Derivative)
  Date: 2026-07-29 | Code: H | Expires: 2030-02-18 | shares_owned_after: 2,000.00 | Footnotes: F11

Footnotes:

• F1: On July 29, 2026, the Reporting Person exercised employee stock options to purchase an aggregate of 4,000 shares of the Issuer's common stock, consisting of options to purchase 2,000 shares at an exercise price of $37.31 per share and options to purchase 2,000 shares at an exercise price of $34.35 per share. The aggregate exercise price of $143,320 was paid through the delivery to the Issuer of 1,830 shares of common stock previously owned by the Reporting Person having an aggregate fair market value of $143,307, together with a cash payment of $13. The surrendered shares are reported in Table I as a disposition.
• F2: Reflects 401(k) contributions that have occurred since the date of the reporting person's last ownership report.
• F3: The options become exercisable in 20% installments over a five year period with the first installment vesting on 1/4/20. Each remaining installment vests annually thereafter.
• F4: The options become exercisable in 20% installments over a five year period with the first installment vesting on 1/16/19. Each remaining installment vests annually thereafter.
• F5: The options become exercisable in 20% installments over a five year period with the first installment vesting on 2/24/27. Each remaining installment vests annually thereafter.
• F6: The options become exercisable in 20% installments over a five year period with the first installment vesting on 2/18/26. Each remaining installment vests annually thereafter.
• F7: The options become exercisable in 20% installments over a five-year period with the first installment vesting on 2/8/25. Each remaining installment vests annually thereafter.
• F8: The options become exercisable in 20% installments over a five-year period with the first installment vesting on 2/21/24. Each remaining installment vests annually thereafter.
• F9: The options become exercisable in 20% installments over a five year period with the first installment vesting on 2/3/23. Each remaining installment vests annually thereafter.
• F10: The options become exercisable in 20% installments over a five year period with the first installment vesting on 2/10/22. Each remaining installment vests annually thereafter.
• F11: The options become exercisable in 20% installments over a five year period with the first installment vesting on 2/18/21. Each remaining installment vests annually thereafter.